Skip to Main Content

Author Details

Christine B Peterson
University of Texas MD Anderson Cancer Center
2013
111
24
PMIDPaper TitleJournal TitlePublished Year
37552151Quantifying the Effect of 4-Dimensional Computed Tomography-Based Deformable Dose Accumulation on Representing Radiation Damage for Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Standard-Fractionated Intensity-Modulated Radiation Therapy.Int J Radiat Oncol Biol Phys2024
36239535Bayesian hierarchical quantile regression with application to characterizing the immune architecture of lung cancer.Biometrics2023
37595283Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up.Blood2023
37527013SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.Clin Cancer Res2023
37481832Low pitch significantly reduces helical artifacts in abdominal CT.Eur J Radiol2023
37657443Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites.Cell Host Microbe2023
37647056Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.JAMA Dermatol2023
37016930Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity.Cancer2023
37045546TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.Int J Gynecol Cancer2023
37307230Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2023
37403975Liver Cancer Vascularity Driven by Extracellular Matrix Stiffness: Implications for Imaging Research.Invest Radiol2023
37138019Venetoclax consolidation in high-risk CLL treated with ibrutinib for â¿¥1 year achieves a high rate of undetectable MRD.Leukemia2023
36968604Bayesian feature selection for radiomics using reliability metrics.Front Genet2023
37034187Sparse tree-based clustering of microbiome data to characterize microbiome heterogeneity in pancreatic cancer.J R Stat Soc Ser C Appl Stat2023
36697347Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans.Pract Radiat Oncol2023
36788067Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.Mod Pathol2023
36443547Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer.Infect Dis Ther2023
36540994Predictive modeling using shape statistics for interpretable and robust quality assurance of automated contours in radiation treatment planning.Pac Symp Biocomput2023
36841341Characterizing the interplay of treatment parameters and complexity and their impact on performance on an IROC IMRT phantom using machine learning.Radiother Oncol2023
34748857Photon beam modeling variations predict errors in IMRT dosimetry audits.Radiother Oncol2022
35650597Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.J Exp Clin Cancer Res2022
35401050Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams.J Radiother Pract2022
35433514Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.Front Cell Infect Microbiol2022
35787928An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check.Int J Radiat Oncol Biol Phys2022
35634713Flow cytometry can reliably capture gut microbial composition in healthy adults as well as dysbiosis dynamics in patients with aggressive B-cell non-Hodgkin lymphoma.Gut Microbes2022
36408172Leveraging deep learning-based segmentation and contours-driven deformable registration for dose accumulation in abdominal structures.Front Oncol2022
36776345Latent Network Estimation and Variable Selection for Compositional Data Via Variational EM.J Comput Graph Stat2022
35941212A phase two study of high dose blinatumomab in Richter's syndrome.Leukemia2022
36074459Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.JAMA Otolaryngol Head Neck Surg2022
35999229Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.Sci Rep2022
36063983Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer.Radiother Oncol2022
36261805Estimating the optimal linear combination of predictors using spherically constrained optimization.BMC Bioinformatics2022
36054779Bayesian sparse modeling to identify high-risk subgroups in meta-analysis of safety data.Res Synth Methods2022
35120564Performance determinants of unsupervised clustering methods for microbiome data.Microbiome2022
34784256Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.Otolaryngol Head Neck Surg2022
32686846Bayesian compositional regression with structured priors for microbiome feature selection.Biometrics2021
36825068Hypotheses on a tree: new error rates and testing strategies.Biometrika2021
33849924Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.J Immunother Cancer2021
33712647Associations between the gut microbiome and fatigue in cancer patients.Sci Rep2021
33731016ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries.BMC Bioinformatics2021
33640315Clinical Acceptability of Automated Radiation Treatment Planning for Head and Neck Cancer Using the Radiation Planning Assistant.Pract Radiat Oncol2021
34941392Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.Science2021
35330584Using FFF Beams to Improve the Therapeutic Ratio of Lung SBRT.J Radiother Pract2021
34705519Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers.Sci Transl Med2021
34680527ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells.Biomedicines2021
34252894Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy.Phys Med Biol2021
34318891A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.J Clin Endocrinol Metab2021
34315823Author response to Cunha <i>et al</i>.J Immunother Cancer2021
34310827Geometric and dosimetric accuracy of deformable image registration between average-intensity images for 4DCT-based adaptive radiotherapy for non-small cell lung cancer.J Appl Clin Med Phys2021
31907855Comparison of ejection fraction calculation between CT and SPECT at high heart rate: A dynamic cardiac phantom study.J Nucl Cardiol2021
  • 1 - 50 of 111

Recommended Authors

Michael Altenbuchinger
University Medical Center Gottingen
Career Start Year 2017
Number of shared co-authors 0
Jeffrey A Thompson
University of Kansas Medical Center
Career Start Year 2013
Number of shared co-authors 2
Osvaldo Espin-Garcia
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Yanxun Xu
Johns Hopkins University
Career Start Year 2011
Number of shared co-authors 1
Kun-Hsing Yu
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 1
Anna Goldenberg
SickKids Research Institute
Career Start Year 2011
Number of shared co-authors 0
Guanhua Chen
University of Wisconsin-Madison
Career Start Year 2009
Number of shared co-authors 0
Jaeil Ahn
Georgetown University
Career Start Year 2008
Number of shared co-authors 0
Brian P Hobbs
Dell Medical School, University of Texas at Austin
Career Start Year 2008
Number of shared co-authors 14
Eunjee Lee
Chungnam National University
Career Start Year 2007
Number of shared co-authors 1
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 2
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 9
Arvind Rao
University of Michigan-Ann Arbor
Career Start Year 2006
Number of shared co-authors 29
Marco Chierici
Fondazione Bruno Kessler
Career Start Year 2006
Number of shared co-authors 0
Jennifer Clarke
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 1
Guanghua Xiao
The University of Texas Southwestern Medical Center
Career Start Year 2005
Number of shared co-authors 3
Richard A Moffitt
Stony Brook University, and Stony Brook Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 2
Jiang Gui
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 0
May D Wang
Georgia Institute of Technology
Career Start Year 2003
Number of shared co-authors 1
Qi Long
and Informatics Perelman School of Medicine, University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 1
Reid F Thompson
Oregon Health and Sciences University
Career Start Year 2002
Number of shared co-authors 2
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 0
Ronghui Xu
University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 15
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 6
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 3
Joseph G Ibrahim
University of North Carolina
Career Start Year 1991
Number of shared co-authors 1
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 1

Collaborators

Laurence E Court
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
David S Followill
University of Texas MD Anderson Cancer Center
Co-authored papers 11
Rebecca M Howell
The University of Texas M. D. Anderson Cancer Center
Co-authored papers 10
Carlos E Cardenas
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Peter Balter
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Radhe Mohan
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Chiara Sabatti
Co-authored papers 6
Brian M Anderson
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Jinzhong Yang
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Beth M Beadle
Stanford University
Co-authored papers 5
Lifei Zhang
The University of Texas MD Anderson Cancer Center.
Co-authored papers 4
Skylar Gay
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Rachel E McCarroll
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Jennifer A Wargo
Co-authored papers 4
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Hester Burger
Groote Schuur Hospital and University of Cape Town
Co-authored papers 3
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Co-authored papers 3
Daniela Branco
University of California San Diego
Co-authored papers 3
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Rivka R Colen
Co-authored papers 3
Hesham Elhalawani
Co-authored papers 3
Kelly Kisling
Moores Cancer Center, University of California San Diego
Co-authored papers 3
Christopher Nelson
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Nelson B Freimer
Co-authored papers 2
Christoph Trauernicht
Stellenbosch University and Tygerberg Academic Hospital
Co-authored papers 2
Amanda R Wasylishen
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Ivette Zelaya
Co-authored papers 2
Min Jin Ha
Co-authored papers 2
Release 1.2